MedTrace Logo

Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)

NCT05144152 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-08-27

No results posted yet for this study

Summary

The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.

Conditions

  • Colorectal Adenoma
  • Advanced Adenoma
  • Colorectal Polyp

Interventions

DIAGNOSTIC_TEST

M3

A panel of four bacterial gene markers (Fn, m3, Ch and Bc)

DIAGNOSTIC_TEST

FIT

faecal immunochemical test

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-13
Primary Completion
2024-12-15
Completion
2025-06-15

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144152 on ClinicalTrials.gov